1-MNA by Longevity Launch Labs

Supplement

1-MNA, a novel myokine, is a game-changer in cellular, vascular, and lipid health by blocking the enzyme NNMT and optimizing NAD levels in the cells.

Services
  • Safely Supports NAD Levels
  • Reduces Inflammatory Proteins
  • Supports Healthy Blood Vessels
Location Boulder, Colorado
About

1-MNA by Longevity Launch Labs

1-MNA or ‘1-methylnicotinamide’ is a unique supplement that helps block the enzyme NNMT, supporting metabolic, brain, and cellular health by optimizing NAD levels.

1-MNA has been shown to inhibit the enzyme NNMT, which when present in high levels, is associated with various diseases. By inhibiting this enzyme, 1-MNA can contribute to overall cellular health and disease prevention.

Researched extensively for its safety profile, 1-MNA supplementation aims to safely restore NAD levels, optimize cellular redox pathways, and combat age-related diseases comprehensively. As a natural byproduct of vitamin B3, 1-MNA also shows anti-inflammatory effects and supports vascular and cardiovascular health, making it a strong candidate for daily use.

* Safely increase NAD levels and block NNMT
* Renowned for its anti-inflammatory and anti-thrombotic qualities
* Improve cell energy metabolism
* Positive effect on Vascular Endothelium
* Lowers levels of inflammatory markers

1-MNA is the flagship supplement of Longevity Launch Labs—affectionately known as Launch. Launch is a dynamic incubator dedicated to fostering groundbreaking products, services, and technologies that address the most pressing challenges in Cellular and Longevity Medicine.

At Launch, we bring years of industry expertise and a deep understanding of the business of medicine to empower founders as they navigate the complexities of today’s healthcare landscape. Our mission is to push the boundaries of innovation and transform the future of healthcare.

Join us in shaping a healthier, longer tomorrow—together.

Unlock exclusive discounts and offers from 1-MNA by Longevity Launch Labs and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

I strongly recommend 1-MNA because it delivers the energy, vascular, and lipid benefits patients are looking for—without the uncertainties that come with NAD precursors. In my clinic, we’ve seen patients experience noticeable improvements in energy and significant gains in lipid profiles, including reductions in Lp(a). Unlike other NAD supplements, which may carry long-term risks, 1-MNA offers a safer, more targeted way to support healthy aging and cellular resilience.

Elizabeth Yurth, MD, ABPMR, ABAARM, FAARM, FAARFM, FSSRP - Co-Founder & Chief Medical Officer - Boulder Longevity Institute Boulder Longevity Institute

Unlike other NAD boosting supplements, 1-MNA is a safe and effective way to restore NAD levels and combat age related diseases, while in addition, improving vascular health, reducing inflammation, having anti-oxidant and neuroprotective properties and improving athletic recovery. I think of it as a kind of “supplement superhero” with a litany of longevity-supporting effects.

Dr. Frank Lipman Founder - Eleven Eleven Wellness Center
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Peptide Therapy Certification 2026
September 11 - 12, 2026

Peptide Therapy Certification 2026

View Event Details
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
SSRP Institute Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
BREAKING NEWS August 26, 2026 – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS
PODCAST
Redox Revolution
Aug 25, 2026
Ep.74 – Girls and Sports Injuries: Is There An Epidemic We’re Not Paying Attention To?
Ep.74 – Girls and Sports Injuries: Is There An Epidemic We’re Not Paying Attention To?

In this episode of Redox Revolution, Dr. Seeds discusses the rising prevalence of sports-related injuries in young women and girls. Why this increase? What’s at stake?

Performance & Recovery · Women's Health
VIDEO
Cellular Medicine Mondays
Aug 24, 2026
Ep. 102 - Office Hours: PWC26 Virtual Summit Part 4
Preview Only
Office Hours PWC26 Virtual Summit Part 4 – Episode 102

Office Hours PWC26 Virtual Summit Part 4- Episode 102

  1. Compounded topical creams and GHK-Cu with microneedling (0:59)
  2. Detoxing before using copper (12:09)
  3. Patient onboarding process (12:54)
  4. Zinc and iron supplementation with GHK-Cu (23:41)
  5. Loss of taste after COVID (25:55)
  6. 3D CT scans for root canals (27:03)
  7. Oral bacteria swabs and GLP-1 effectiveness (28:00)
  8. Endocannabinoid system (29:07)
  9. GHK-Cu efficacy on wound beds (32:05)

Preview Only — Become a member for full access
SSRP Institute Aug 21, 2026
Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC
HEADLINE SCIENCE JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the molecule into the body, […]
READ NEWS
IntellxxDNA Aug 12, 2026
SSRP Institute Welcomes IntellxxDNA as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP’s mission to advance science-first, education-driven clinical collaboration. IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using […]
READ NEWS
ARTICLE
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
William Seeds, MD Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
SSRP Institute Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS
ARTICLE
William Seeds, MD
Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
William Seeds, MD Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
After a recent Journal Club episode in which I featured, The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation, I wanted to return to the article and expand a bit on the significance of the Renin–Angiotensin–Aldosterone System (RAAS). As we know, the RAAS system has traditionally been viewed as the body’s primary mechanism for regulating blood pressure, […]
READ ARTICLE
World Congress World Congress
Peptide World Congress 2026
At Peptide World Congress 2026, join the fastest-growing community of evidence-based providers exploring the therapeutic power of clinical peptides. Learn why the body ages, when disease originates, and how top clinicians are changing their patients’ lives by treating the body...
22 Lessons
13 Hours 10 Minutes
View Course
ARTICLE
Scott Sherr, MD
Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD | Lucía González Forte, PhD  Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling. At therapeutic oral doses, MB acts as a catalytic electron […]
READ ARTICLE